An integrated approach to the management of IBS

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 7, 2007, Pages 354-355

  Jones, Roger ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ALVERINE; ANTIDIARRHEAL AGENT; CILANSETRON; LAXATIVE; LOPERAMIDE; MEBEVERINE; PROBIOTIC AGENT; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CHOLECYSTECTOMY; COGNITIVE THERAPY; CONSTIPATION; COST OF ILLNESS; DEPRESSION; DETRUSOR MUSCLE; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEALTH CARE ORGANIZATION; HYPNOSIS; HYSTERECTOMY; IRRITABLE COLON; ITALY; MANAGED CARE; MUSCLE DISEASE; PACIFIC ISLANDS; PELVIS PAIN SYNDROME; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SOUTHEAST ASIA; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PSYCHOSOMATIC DISORDER; RELAXATION TRAINING; REVIEW; RISK ASSESSMENT; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPNOSIS; INCIDENCE; IRRITABLE BOWEL SYNDROME; MALE; PROGNOSIS; PSYCHOPHYSIOLOGIC DISORDERS; RELAXATION TECHNIQUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 34447636413     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0845     Document Type: Article

References (10)

1. Longstreth GF et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480-1491
2. Thompson WG et al. (1997) Irritable bowel syndrome. the view from general practice. Eur J Gastroenterol Hepatol 9: 689-692.
3. Kang J (2005) Systematic review: The influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 21: 663-676
4. Cukier JM et al. (1997) A case-control study to examine any association between idiopathic detrusor instability and gastrointestinal tract disorder, and between irritable bowel syndrome and urinary tract disorder. Br J Uro 79: 865-878
5. Chang L (2004) Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (Suppl 7) 31-39
6. Drossman DA et al. (1988) Psychosocial factors in irritable bowel syndrome: A multivariate analysis of patients and non-patients with irritable bowel syndrome. Gastroenterology 95: 701-708
7. Whorwell PJ (2005) The history of hypnotherapy and its role in the irritable bowel syndrome. Aliment Pharmacol Ther 22: 1061-1067
8. Kennedy T et al. (2005) Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomized controlled trial. BMJ 331: 435-437
9. Nimnuan C et al. (2001) How many functional somatic syndromes? J Psychosom Res 51: 549-557
10. Chambers D et al. (2006) Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/ myalgic encephalomyelitis: An updated systematic review. J R Soc Med 99: 506-620